BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19399678)

  • 1. High dose rate radiation treatment of experimental intramuscular prostate carcinoma.
    Skourou C; Hoopes PJ; Gibbs-Strauss SL; Gladstone DJ; Strawbridge R; Paulsen KD
    Int J Radiat Biol; 2009 Apr; 85(4):330-7. PubMed ID: 19399678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation sensitivity of Copenhagen rat prostatic carcinoma (R3327-AT and R3327-MATLyLu).
    Rao BR; Slotman BJ; Geldof AA; Perez CA
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):981-5. PubMed ID: 2022524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial radiation and hyperthermia in the Dunning R3327 prostate tumour model: therapeutic efficacy depends on radiation dose-rate, sequence and frequency of heating.
    Peschke P; Hahn EW; Wolber G; Hildenbrand D; Zuna I
    Int J Radiat Biol; 1996 Nov; 70(5):609-16. PubMed ID: 8947543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent differential effects of low and pulsed dose-rate brachytherapy in a radioresistant syngenic rat prostate tumour model.
    Harms W; Peschke P; Weber KJ; Hensley FW; Wolber G; Debus J; Wannenmacher M
    Int J Radiat Biol; 2002 Jul; 78(7):617-23. PubMed ID: 12079541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved therapeutic response by distinct timing of multiple heat treatments during interstitial radiation in the Dunning R3327 prostate tumor model.
    Peschke P; Heimburg S; Wolber G; Zuna I; Hahn EW
    J Cancer Res Clin Oncol; 1998; 124(3-4):172-8. PubMed ID: 9619743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated radiotherapy of rat prostatic adenocarcinoma (Dunning R3327-PAP) in nonanesthetized animals.
    Granfors T; Bergh A; Löfroth PO; Widmark A
    Prostate; 1999 Apr; 39(1):16-22. PubMed ID: 10221261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of CLDR and PDR brachytherapy on cell cycle progression in a syngeneic rat prostate tumour model.
    Harms W; Weber KJ; Ehemann V; Zuna I; Debus J; Peschke P
    Int J Radiat Biol; 2006 Mar; 82(3):191-6. PubMed ID: 16638716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The radiation sensitivities of R3327-H and R3327-AT rat prostate adenocarcinomas.
    Thorndyke C; Meeker BE; Thomas G; Lakey WH; McPhee MS; Chapman JD
    J Urol; 1985 Jul; 134(1):191-8. PubMed ID: 4009821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery of the rat dunning R3327-AT1 prostate tumor.
    Henke K; Hartmann GH; Peschke P; Hahn EW
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):385-91. PubMed ID: 8892464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions.
    Pollack A; Ashoori F; Sikes C; Joon DL; von Eschenbach AC; Zagars GK; Meistrich ML
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):153-8. PubMed ID: 10656387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of Dunning R3327 prostatic adenocarcinoma to IL-2, histamine and radiation.
    Johansson S; Landström M; Hellstrand K; Henriksson R
    Br J Cancer; 1998 Apr; 77(8):1213-9. PubMed ID: 9579825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response?
    Arai TJ; Yang DM; Campbell JW; Chiu T; Cheng X; Stojadinovic S; Peschke P; Mason RP
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1519-1529. PubMed ID: 33775857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relative biological effectiveness (RBE) of fast neutrons on the Dunning rat prostate carcinoma R3327-HI].
    Wenz F; Lohr F; Peschke P; Wolber G; Höver KH; Hahn EW
    Strahlenther Onkol; 1993 Jul; 169(7):412-7. PubMed ID: 8342114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer.
    Carlson DJ; Stewart RD; Li XA; Jennings K; Wang JZ; Guerrero M
    Phys Med Biol; 2004 Oct; 49(19):4477-91. PubMed ID: 15552412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of the rat Dunning R3327-AT1 prostate tumor to treatment with fractionated fast neutrons.
    Peschke P; Lohr F; Hahn EW; Wolber G; Hoever KH; Wenz F; Lorenz WJ
    Radiat Res; 1992 Jan; 129(1):112-4. PubMed ID: 1728053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tobacco smoke on tumor growth and radiation response of dunning R3327 prostate adenocarcinoma in rats.
    Johansson S; Landström M; Bjermer L; Henriksson R
    Prostate; 2000 Mar; 42(4):253-9. PubMed ID: 10679754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay.
    Tien CJ; Carlson DJ; Nath R; Chen ZJ
    Brachytherapy; 2019; 18(5):701-710. PubMed ID: 31109870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of Radiation at the Lowest Dose Rate by a Modern Linear Accelerator is Most Effective in Inhibiting Prostate Cancer Growth.
    Tazat K; Reshetnyak O; Shtraus N; Sayag I; Mabjeesh NJ; Amir S
    Technol Cancer Res Treat; 2020; 19():1533033820935525. PubMed ID: 32608338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.